Journal of Psychology & Psychotherapy
Open Access

Department of Psychiatry, Royal Prince Alfred Hospital, Missenden Road, Camperdown NSW 2050, Sydney, Australia

Publications

• Mini Review   
  Treating Schizophrenia Thinking beyond the Choice of Antipsychotic
  Author(s): William Lugg*
  
  The treatment of schizophrenia has evolved over the past half century primarily in the context of antipsychotic drug development. Although there has been significant progress resulting in the availability and use of numerous medications, these reflect three basic classes of medications (conventional (typical), atypical and dopamine partial agonist antipsychotics) all of which, despite working by varying mechanisms of actions, act principally on dopamine systems. Many of the second-generation (atypical and dopamine partial agonist) antipsychotics are believed to offer advantages over first-generation agents in the treatment for schizophrenia. However, the pharmacological properties that confer the different therapeutic effects of the new generation of antipsychotic drugs have remained elusive, and certain side effects can still impact patient health and quality of .. View More»
  DOI: 10.35248/2161-0487.21.11.413

  Abstract HTML PDF